Confo Therapeutics is based in Ghent, Belgium. It has raised $106M in total funding. Latest round: Series B.
Confo Therapeutics is based in Ghent, Belgium. Confo Therapeutics has raised $106M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in July 2024. The round record for Confo Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Ackermans & van Haaren, Driehaus Capital Management, Quest for Growth, BioGeneration Ventures, Capricorn Health-tech Fund, Fund+ and 7 others. 13 distinct backers are named across the disclosed rounds.
Round data for Confo Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Ghent and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026